New Zealand markets open in 58 minutes

MRNA Sep 2022 340.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.81000.0000 (0.00%)
As of 09:37AM EDT. Market open.
Full screen
Previous close0.8100
Open0.8100
Bid0.0500
Ask0.4500
Strike340.00
Expiry date2022-09-16
Day's range0.8100 - 0.8100
Contract rangeN/A
Volume1
Open interest249
  • Zacks

    Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response

    Pfizer (PFE) and partner BioNTech's (BNTX) Omicron-specific COVID vaccine candidates achieves a higher immune response against the variant in a phase II/III study.

  • Motley Fool

    Could This Be Moderna's Ticket to Long-Term Success?

    Moderna (NASDAQ: MRNA) waited a long time to reach this important moment: the authorization of its vaccine in infants and children. This month, the FDA authorized the vaccine for both teens and children ages six months and older, and vaccine rollout has begun for the youngest group. Could this new authorization be Moderna's ticket to long-term success?

  • Motley Fool

    2 Biotech Stocks That Could Make You Richer

    The biotech industry hasn't performed well this year, even by the standards of the struggling stock market. The SPDR S&P Biotech ETF -- an industry benchmark -- is down by 36% year to date. The good news is that there are still plenty of great biotech stocks that could be solid long-term picks.